Clinical Trials

150 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT07286266 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

450 enrolled

Ovarian Neoplasms

NCT07286331 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

600 enrolled

Endometrial Neoplasms

NCT07459634 2026-05-27

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

50 enrolled

Small Cell Lung Carcinoma

NCT07544654 2026-05-27

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

390 enrolled

Endocrine

Extrapulmonary Neuroendocrine Cancer

NCT07607925 2026-05-27

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

49 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT07609251 2026-05-27

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07609472 2026-05-27

FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

76 enrolled

CNS

Glioma

NCT07609706 2026-05-27

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

Plasma cell

Multiple Myeloma

NCT07609823 2026-05-27

A Phase 2 Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

LymphoidOther hematologic neoplasm

75 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07609862 2026-05-27

A Phase Ib/II Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

LymphoidOther hematologic neoplasm

92 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07609940 2026-05-27

POPLIN

Phase 4 Not yet recruiting

30 enrolled

Plasma cell

Cytokine Release Syndrome, Multiple Myeloma

NCT07610148 2026-05-27

A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

21 enrolled

Breast Neoplasms

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Solid Tumors

NCT07605962 2026-05-26

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

140 enrolled

Advanced Cancer

NCT07606599 2026-05-26

A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure

398 enrolled

Biliary Tract Neoplasms

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

31 enrolled

Phase NA Not yet recruiting

Solid Tumor

NCT07606963 2026-05-26

CARE II

40 enrolled

Colorectal Neoplasms

NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

50 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07607327 2026-05-26

FORWARD

Classical hematologyOther hematologic neoplasm

400 enrolled

Anemia, Refractory, with Excess of Blasts, Recurrence, Leukemia, Myeloid, Acute

NCT07287098 2026-05-22

preEMBER

600 enrolled

Breast Neoplasms

NCT07541079 2026-05-22

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

300 enrolled

Breast Neoplasms

NCT07582315 2026-05-22

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

538 enrolled

Biliary Tract Neoplasms

NCT07600749 2026-05-22

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

120 enrolled

Tumor-Agnostic

Neoplasms

NCT07601048 2026-05-22

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

450 enrolled

KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

NCT07601204 2026-05-22

Treatment of Recurrent/Metastatic Head and Neck Cancer

128 enrolled

Head & Neck

Head and Neck Neoplasms

NCT07601243 2026-05-22

Study of GS-2426 in Participants With Advanced Solid Tumors

174 enrolled

Advanced Solid Tumors

NCT07601334 2026-05-22

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

45 enrolled

Advanced Solid Tumors

NCT07601620 2026-05-22

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

258 enrolled

Breast Neoplasms

NCT07602777 2026-05-22

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

113 enrolled

Sarcoma

NCT07602842 2026-05-22

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

GastrointestinalHead & Neck

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Carcinoma, Squamous Cell, Neoplasm Metastasis

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

184 enrolled

Solid Tumors

NCT07603479 2026-05-22

A Phase I Study of JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

14 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms

NCT07603791 2026-05-22

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

252 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07604285 2026-05-22

NOVA-GBM

36 enrolled

CNS

Glioblastoma

NCT07604766 2026-05-22

RAINFOL-02

82 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07597993 2026-05-20

BEYOND

109 enrolled

Breast Neoplasms

NCT07599007 2026-05-20

Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07600554 2026-05-20

SWAP

Genitourinary

Prostatic Neoplasms

NCT07387926 2026-05-19

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

LymphoidOther hematologic neoplasm

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07412275 2026-05-19

MILA

Phase NA Not yet recruiting

Genitourinary

Localised Prostate Cancer

NCT07486817 2026-05-19

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

60 enrolled

Lung Neoplasms

NCT07578649 2026-05-19

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

600 enrolled

Endometrial Neoplasms

NCT07595276 2026-05-19

Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.

608 enrolled

Colorectal Neoplasms

NCT07595913 2026-05-19

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

240 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT07596381 2026-05-19

FAK Inhibitor in Patients With Advanced Solid Tumors

75 enrolled

Advanced Solid Tumors

NCT07596784 2026-05-19

Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)

Myasthenia Gravis

NCT07597629 2026-05-19

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

114 enrolled

Advanced Breast Cancer

NCT07454850 2026-05-18

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

MyeloidOther hematologic neoplasm

400 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT07593092 2026-05-18

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

90 enrolled